| Name | Title | Contact Details |
|---|---|---|
Grey Hodge |
Chief Information Officer | Profile |
Accovion Inc. is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BIOCIUS Life Sciences is a Wakefield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Community Health Network of Connecticut Foundation is a Wallingford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Robin Healthcare is an innovative healthcare partner that combines the power of artificial intelligence (AI), voice recognition, and domestic virtual medical scribes and care coordinators to solve healthcare biggest challenges and inefficiencies.